|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/444 | (2006.01) |
| A61P 7/00 | (2006.01) |
| (11) | Number of the document | 3982960 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20734283.3 |
| Date of filing the European patent application | 2020-06-15 | |
| (97) | Date of publication of the European application | 2022-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-28 |
| (46) | Date of publication of the claims translation | 2023-08-25 |
| (86) | Number | PCT/GB2020/051439 |
| Date | 2020-06-15 |
| (87) | Number | WO 2020/249977 |
| Date | 2020-12-17 |
| (30) | Number | Date | Country code |
| 201962861725 P | 2019-06-14 | US | |
| 201910116 | 2019-07-15 | GB |
| (72) |
FEENER, Edward Paul , US
MARSH, Sally Louise , GB
MAETZEL, Andreas , US
SMITH, Michael David , US
YEA, Christopher Martyn , GB
|
| (73) |
Kalvista Pharmaceuticals Limited ,
Porton Science Park
Bybrook Road, Porton Down, Salisbury SP4 0BF
Wiltshire,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Paveldimos angioedemos gydymo būdai |
| TREATMENTS OF HEREDITARY ANGIOEDEMA |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 6 | 139.00 EUR |
| 2026-06-15 |